DNA methylation in cystathionine-γ-lyase (CSE) gene promoter induced by ox-LDL in macrophages and in apoE knockout mice

Biochemical and Biophysical Research Communications

Volumn 469, Issue 3, 2016, Pages 776-782

  Du, Hua Ping ^a   Li, Jiaojiao ^a   You, Shou Jiang ^a   Wang, Ya Li ^a   Wang, Fen ^a   Cao, Yong Jun ^a   Hu, Li Fang ^a,b   Liu, Chun Feng ^a,b,c  

^a SOOCHOW UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c Beijing Key Laboratory for Parkinson's Disease   (China)

Author keywords

Atherosclerosis; Cystathionine lyase; DNA methylation; Hydrogen sulfide; Macrophage; ox LDL

Indexed keywords

APOLIPOPROTEIN E; CYSTATHIONINE GAMMA LYASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; HIGH DENSITY LIPOPROTEIN; HYDROGEN SULFIDE; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; SMALL INTERFERING RNA; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CELL ISOLATION; CELL LINE RAW 264.7; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; ENZYME INHIBITION; GENE EXPRESSION; GENETIC TRANSCRIPTION; IN VITRO STUDY; LIPID DIET; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BLOOD; C57BL MOUSE; CELL CULTURE; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; MACROPHAGE; PHYSIOLOGY; RAW 264.7 CELL LINE;

ANIMALS; CELLS, CULTURED; CYSTATHIONINE GAMMA-LYASE; DNA METHYLATION; HYDROGEN SULFIDE; LIPOPROTEINS, LDL; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROMOTER REGIONS, GENETIC; RAW 264.7 CELLS;

EID: 84953637828     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.11.132     Document Type: Article

References (22)

1. V. Grimaldi, M.T. Vietri, C. Schiano, A. Picascia, M.R. De Pascale, C. Fiorito, A. Casamassimi, and C. Napoli Epigenetic reprogramming in atherosclerosis Curr. Atheroscler. Rep. 17 2015 476
2. J.L. Wallace, and R. Wang Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter Nat. Rev. Drug Discov. 14 2015 329 345
3. A.M. Koning, A.R. Frenay, H.G. Leuvenink, and H. van Goor Hydrogen sulfide in renal physiology, disease and transplantation-the smell of renal protection Nitric Oxide Biol. Chem. Off. J. Nitric Oxide Soc. 46 2015 37 49
4. S. Mani, W. Cao, L. Wu, and R. Wang Hydrogen sulfide and the liver Nitric Oxide Biol. Chem. Off. J. Nitric Oxide Soc. 41 2014 62 71
5. S. Mani, A. Untereiner, L. Wu, and R. Wang Hydrogen sulfide and the pathogenesis of atherosclerosis Antioxid. Redox Signal. 20 2014 805 817
6. Y. Wang, X. Zhao, H. Jin, H. Wei, W. Li, D. Bu, X. Tang, Y. Ren, C. Tang, and J. Du Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice Arterioscler. Thromb. Vasc. Biol. 29 2009 173 179
7. A. Ford, M. Al-Magableh, T.A. Gaspari, and J.L. Hart Chronic NaHS treatment is vasoprotective in high-fat-fed ApoE(-/-) mice Int. J. Vasc. Med. 2013 2013 915983
8. S. Mani, H. Li, A. Untereiner, L. Wu, G. Yang, R.C. Austin, J.G. Dickhout, S. Lhotak, Q.H. Meng, and R. Wang Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis Circulation 127 2013 2523 2534
9. X.H. Wang, F. Wang, S.J. You, Y.J. Cao, L.D. Cao, Q. Han, C.F. Liu, and L.F. Hu Dysregulation of cystathionine gamma-lyase (CSE)/hydrogen sulfide pathway contributes to ox-LDL-induced inflammation in macrophage Cell. Signal. 25 2013 2255 2262
10. J.J. Li, Q. Li, H.P. Du, Y.L. Wang, S.J. You, F. Wang, X.S. Xu, J. Cheng, Y.J. Cao, C.F. Liu, and L.F. Hu Homocysteine triggers inflammatory responses in macrophages through inhibiting CSE-H2S signaling via DNA hypermethylation of CSE promoter Int. J. Mol. Sci. 16 2015 12560 12577
11. H. Peng, Y. Cheng, C. Dai, A.L. King, B.L. Predmore, D.J. Lefer, and B. Wang A fluorescent probe for fast and quantitative detection of hydrogen sulfide in blood Angew. Chem. 50 2011 9672 9675
12. Y. Xu, H.P. Du, J. Li, R. Xu, Y.L. Wang, S.J. You, H. Liu, F. Wang, Y.J. Cao, C.F. Liu, and L.F. Hu Statins upregulate cystathionine gamma-lyase transcription and H2S generation via activating Akt signaling in macrophage Pharmacol. Res. Off. J. Italian Pharmacol. Soc. 87 2014 18 25
13. J.G. Herman, J.R. Graff, S. Myohanen, B.D. Nelkin, and S.B. Baylin Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands Proc. Natl. Acad. Sci. U. S. A. 93 1996 9821 9826
14. H.H. Zhang, J. Hu, Y.L. Zhou, S. Hu, Y.M. Wang, W. Chen, Y. Xiao, L.Y. Huang, X. Jiang, and G.Y. Xu Promoted interaction of nuclear factor-kappaB with demethylated cystathionine-beta-synthetase gene contributes to gastric hypersensitivity in diabetic rats J. Neurosci. Off. J. Soc. Neurosci. 33 2013 9028 9038
15. R. Wang Physiological implications of hydrogen sulfide: a whiff exploration that blossomed Physiol. Rev. 92 2012 791 896
16. R. Ross Atherosclerosis-an inflammatory disease N. Engl. J. Med. 340 1999 115 126
17. S. Zaina, H. Heyn, F.J. Carmona, N. Varol, S. Sayols, E. Condom, J. Ramirez-Ruz, A. Gomez, I. Goncalves, S. Moran, and M. Esteller DNA methylation map of human atherosclerosis Circ. Cardiovasc. Genet. 7 2014 692 700
18. G. Lund, L. Andersson, M. Lauria, M. Lindholm, M.F. Fraga, A. Villar-Garea, E. Ballestar, M. Esteller, and S. Zaina DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E J. Biol. Chem. 279 2004 29147 29154
19. M.O. Hiltunen, M.P. Turunen, T.P. Hakkinen, J. Rutanen, M. Hedman, K. Makinen, A.M. Turunen, K. Aalto-Setala, and S. Yla-Herttuala DNA hypomethylation and methyltransferase expression in atherosclerotic lesions Vasc. Med. 7 2002 5 11
20. M.P. Turunen, E. Aavik, and S. Yla-Herttuala Epigenetics and atherosclerosis Biochim. Biophys. Acta 1790 2009 886 891
21. M.O. Hiltunen, and S. Yla-Herttuala DNA methylation, smooth muscle cells, and atherogenesis Arterioscler. Thromb. Vasc. Biol. 23 2003 1750 1753
22. A.E. Neele, J. Van den Bossche, M.A. Hoeksema, and M.P. de Winther Epigenetic pathways in macrophages emerge as novel targets in atherosclerosis Eur. J. Pharmacol. 763 2015 79 89